Minzasolmin
Minzasolmin (DLX-313) is a small molecule inhibitor that targets the misfolding of alpha-synuclein. It is a research tool used in both in vitro and in vivo studies to investigate the pathological mechanisms and potential therapeutic strategies for Parkinson's disease.
Product Specifications
CAS Number
1802518-92-8
Product Name Alternative
DLX-313, (R) -NPT200-11, UCB0599, α-synuclein
Purity
98.31% (May vary between batches)
Smiles
C ([C@H] (NC (=O) C=1SC (=NC1) N2CCN (C) CC2) CCCC) C=3C=4C (NC3) =CC=CC4
Molecular Formula
C23H31N5OS
Molecular Weight
425.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15150455 1 Vial
Lentiviral mouse Cplx2 shRNA (UAS) - Lentiviral mouse Cplx2 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details OR28527 1 Each
3- (4-chlorophenyl) -1- (5-chloro-2-thienyl) prop-2-en-1-one
Sign In for Pricing
View Details 